MyBPC3 Antibody [Alexa Fluor® 488]

• Applications: WB, IHC
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: Alexa Fluor 488

MyBPC3 Antibody [Alexa Fluor® 488] Summary

• Immunogen: E. coli-derived recombinant human MyBPC3
  Arg1001-Lys1103
  Accession # Q14896
• Specificity: Detects human MyBPC3 in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant mouse MyBPC3 is observed.
• Source: N/A
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Purity Statement: Antigen Affinity-purified

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Background

MyBPC3 (MYosin Binding Protein C3; also cardiac MyBP-C, and C-protein, cardiac muscle isoform) is a 150-165 kDa member of the MyBP family, immunoglobulin superfamily of molecules. MyBP-C is expressed in striated muscle and exists in three isoforms; C1, C2, and C3. C1 and C2 are associated with slow and fast skeletal muscle, and may coexist in the same myofiber. The C3 isoform is cardiac specific, and is found in the two dark C-zones that flank the M line of the sarcomere A-band. The A-band contains both actin and myosin, and MyBPC3 forms structures that cross-link the resident actin and myosin filaments. MyBPC3 is reported to interact with titin and light meromyosin with its C-terminus, and actin plus myosin heavy chain with its N-terminus. Human MyBPC3 is 1273 amino acids (aa) in length. It contains one N-terminal I-set Ig-like domain (aa 12-94), a C2-type Ig-like domain (aa 153-256) followed by a phosphorylated myosin-binding region (aa 258-352), four C2-type Ig-like domains (aa 362-770) and three FN type III repeats interspersed with two C2-type Ig-like domains (aa 771-1273). There is one potential alternative start site at Met348. Over aa 1001-1103, human MyBPC3 shares 89% aa identity with mouse MyBPC3.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.